Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Therapy for PTSD in Frontline Healthcare Workers and First Responders
NCT05455996Phase 2Not yet recruiting
- Sponsor
- Nautilus Sanctuary
- Start
- Oct 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD), adjustment disorder (AD), sponsored by Nautilus Sanctuary. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)adjustment disorder (AD)
Beyond the preview
Go deeper on NCT05455996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05455996.